HEADER TRANSLATION/ANTIBIOTIC 19-JUN-12 4FN5 TITLE ELONGATION FACTOR G 1 (PSEUDOMONAS AERUGINOSA) IN COMPLEX WITH ARGYRIN TITLE 2 B COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION FACTOR G 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EF-G 1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ARGYRIN B; COMPND 8 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 208964; SOURCE 4 STRAIN: ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228; SOURCE 5 GENE: FUSA, FUSA1, PA4266; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ACTINOPLANES SP.; SOURCE 10 ORGANISM_TAXID: 1871; SOURCE 11 STRAIN: 86317 KEYWDS ELONGATION FACTOR, TRANSLATION, TRANSLATION-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.A.KIRBY,D.PALESTRANT REVDAT 1 26-SEP-12 4FN5 0 JRNL AUTH B.NYFELER,D.HOEPFNER,D.PALESTRANT,C.A.KIRBY,L.WHITEHEAD, JRNL AUTH 2 R.YU,G.DENG,R.E.CAUGHLAN,A.L.WOODS,A.K.JONES,S.W.BARNES, JRNL AUTH 3 J.R.WALKER,S.GAULIS,E.HAUY,S.M.BRACHMANN,P.KRASTEL,C.STUDER, JRNL AUTH 4 R.RIEDL,D.ESTOPPEY,T.AUST,N.R.MOVVA,Z.WANG,M.SALCIUS, JRNL AUTH 5 G.A.MICHAUD,G.MCALLISTER,L.O.MURPHY,J.A.TALLARICO, JRNL AUTH 6 C.J.WILSON,C.R.DEAN JRNL TITL IDENTIFICATION OF ELONGATION FACTOR G AS THE CONSERVED JRNL TITL 2 CELLULAR TARGET OF ARGYRIN B. JRNL REF PLOS ONE V. 7 42657 2012 JRNL REFN ESSN 1932-6203 JRNL PMID 22970117 JRNL DOI 10.1371/JOURNAL.PONE.0042657 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.300 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 857 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.13 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2715 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2483 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2569 REMARK 3 BIN R VALUE (WORKING SET) : 0.2436 REMARK 3 BIN FREE R VALUE : 0.3365 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.38 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5237 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 84.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.01850 REMARK 3 B22 (A**2) : -9.51650 REMARK 3 B33 (A**2) : 11.53500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 29.56810 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.42 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.885 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.825 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5322 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7180 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1905 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 146 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 764 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5322 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 692 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6036 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 22.09 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FN5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-12. REMARK 100 THE RCSB ID CODE IS RCSB073107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16883 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 71.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION WAS INCUBATED WITH REMARK 280 LIGAND FOR 1 HOUR. EQUAL VOLUMES OF RESERVOIR SOLUTION AND REMARK 280 PROTEIN SOLUTION WERE MIXED. RESERVOIR SOLUTION: 100MM TRIS HCL REMARK 280 PH 7.5, 18% PEG3350, 0.2M SODIUM NITRATE. PROTEIN SOLUTION: 50MM REMARK 280 TRIS HCL PH7.5, 150MM NACL, 1MM TCEP , VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 62.89000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 62.89000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLY A 41 REMARK 465 GLU A 42 REMARK 465 VAL A 43 REMARK 465 HIS A 44 REMARK 465 ASP A 45 REMARK 465 GLY A 46 REMARK 465 ALA A 47 REMARK 465 ALA A 48 REMARK 465 THR A 49 REMARK 465 THR A 50 REMARK 465 ASP A 51 REMARK 465 TRP A 52 REMARK 465 MET A 53 REMARK 465 VAL A 54 REMARK 465 GLN A 55 REMARK 465 GLU A 56 REMARK 465 GLN A 57 REMARK 465 GLU A 58 REMARK 465 ARG A 59 REMARK 465 GLY A 60 REMARK 465 ILE A 61 REMARK 465 THR A 62 REMARK 465 ILE A 63 REMARK 465 THR A 64 REMARK 465 ASP A 196 REMARK 465 ASP A 197 REMARK 465 ASP A 302 REMARK 465 ARG A 408 REMARK 465 MET A 409 REMARK 465 ASP A 410 REMARK 465 PHE A 411 REMARK 465 GLU A 529 REMARK 465 VAL A 544 REMARK 465 GLY A 706 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 4 -85.21 -147.71 REMARK 500 HIS A 18 -72.94 -121.92 REMARK 500 VAL A 19 -76.19 -93.74 REMARK 500 THR A 116 -88.61 -81.93 REMARK 500 ALA A 175 -83.04 -66.67 REMARK 500 GLU A 176 -89.81 -112.00 REMARK 500 ALA A 209 -38.62 -36.95 REMARK 500 GLU A 228 27.31 -78.02 REMARK 500 ALA A 229 -70.84 -82.46 REMARK 500 ASN A 272 -14.12 57.37 REMARK 500 ALA A 311 72.23 -61.68 REMARK 500 VAL A 349 -168.61 -112.95 REMARK 500 ASN A 351 58.93 -98.33 REMARK 500 SER A 352 -29.52 -28.03 REMARK 500 LYS A 354 -76.54 -74.53 REMARK 500 GLU A 372 106.95 2.89 REMARK 500 LYS A 389 -124.25 -73.82 REMARK 500 LEU A 406 -70.99 -74.85 REMARK 500 GLU A 421 142.01 -172.36 REMARK 500 LYS A 425 -29.50 -31.65 REMARK 500 GLN A 428 -52.71 -5.74 REMARK 500 ARG A 475 -95.31 -91.28 REMARK 500 GLU A 476 -10.28 -43.25 REMARK 500 VAL A 569 -69.07 -98.75 REMARK 500 PHE A 582 -14.34 -140.31 REMARK 500 ASP A 588 -37.70 -22.51 REMARK 500 GLN A 609 -51.30 -121.89 REMARK 500 VAL A 652 -71.75 -23.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 HIS A 18 23.3 L L OUTSIDE RANGE REMARK 500 VAL A 99 24.3 L L OUTSIDE RANGE REMARK 500 VAL A 111 24.9 L L OUTSIDE RANGE REMARK 500 PHE A 179 24.0 L L OUTSIDE RANGE REMARK 500 TRP A 193 24.9 L L OUTSIDE RANGE REMARK 500 VAL A 342 23.8 L L OUTSIDE RANGE REMARK 500 GLU A 372 24.1 L L OUTSIDE RANGE REMARK 500 VAL A 418 24.5 L L OUTSIDE RANGE REMARK 500 GLN A 428 24.8 L L OUTSIDE RANGE REMARK 500 ILE A 501 24.8 L L OUTSIDE RANGE REMARK 500 VAL A 568 24.9 L L OUTSIDE RANGE REMARK 500 ILE A 645 24.4 L L OUTSIDE RANGE REMARK 500 PHE A 667 24.3 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF ARGYRIN B DBREF 4FN5 A 1 706 UNP Q9HWD2 EFG1_PSEAE 1 706 DBREF 4FN5 B 1 8 PDB 4FN5 4FN5 1 8 SEQADV 4FN5 GLY A -2 UNP Q9HWD2 EXPRESSION TAG SEQADV 4FN5 SER A -1 UNP Q9HWD2 EXPRESSION TAG SEQADV 4FN5 HIS A 0 UNP Q9HWD2 EXPRESSION TAG SEQRES 1 A 709 GLY SER HIS MET ALA ARG THR THR PRO ILE ASN ARG TYR SEQRES 2 A 709 ARG ASN ILE GLY ILE CYS ALA HIS VAL ASP ALA GLY LYS SEQRES 3 A 709 THR THR THR THR GLU ARG VAL LEU PHE TYR THR GLY VAL SEQRES 4 A 709 ASN HIS LYS LEU GLY GLU VAL HIS ASP GLY ALA ALA THR SEQRES 5 A 709 THR ASP TRP MET VAL GLN GLU GLN GLU ARG GLY ILE THR SEQRES 6 A 709 ILE THR SER ALA ALA VAL THR THR PHE TRP LYS GLY SER SEQRES 7 A 709 ARG GLY GLN TYR ASP ASN TYR ARG VAL ASN VAL ILE ASP SEQRES 8 A 709 THR PRO GLY HIS VAL ASP PHE THR ILE GLU VAL GLU ARG SEQRES 9 A 709 SER LEU ARG VAL LEU ASP GLY ALA VAL VAL VAL PHE CYS SEQRES 10 A 709 GLY THR SER GLY VAL GLU PRO GLN SER GLU THR VAL TRP SEQRES 11 A 709 ARG GLN ALA ASN LYS TYR GLY VAL PRO ARG ILE VAL TYR SEQRES 12 A 709 VAL ASN LYS MET ASP ARG GLN GLY ALA ASN PHE LEU ARG SEQRES 13 A 709 VAL VAL GLU GLN ILE LYS LYS ARG LEU GLY HIS THR PRO SEQRES 14 A 709 VAL PRO VAL GLN LEU ALA ILE GLY ALA GLU GLU ASN PHE SEQRES 15 A 709 VAL GLY GLN VAL ASP LEU ILE LYS MET LYS ALA ILE TYR SEQRES 16 A 709 TRP ASN ASP ASP ASP LYS GLY MET THR TYR ARG GLU GLU SEQRES 17 A 709 GLU ILE PRO ALA GLU LEU LYS ASP LEU ALA GLU GLU TRP SEQRES 18 A 709 ARG SER SER MET VAL GLU ALA ALA ALA GLU ALA ASN GLU SEQRES 19 A 709 GLU LEU MET ASN LYS TYR LEU GLU GLU GLY GLU LEU SER SEQRES 20 A 709 GLU ALA GLU ILE LYS GLU GLY LEU ARG LEU ARG THR LEU SEQRES 21 A 709 ALA CYS GLU ILE VAL PRO ALA VAL CYS GLY SER SER PHE SEQRES 22 A 709 LYS ASN LYS GLY VAL PRO LEU VAL LEU ASP ALA VAL ILE SEQRES 23 A 709 ASP TYR LEU PRO ALA PRO THR GLU ILE PRO ALA ILE LYS SEQRES 24 A 709 GLY VAL SER PRO ASP ASP GLU THR VAL GLU ASP GLU ARG SEQRES 25 A 709 HIS ALA ASP ASP ASN GLU PRO PHE SER SER LEU ALA PHE SEQRES 26 A 709 LYS ILE ALA THR ASP PRO PHE VAL GLY THR LEU THR PHE SEQRES 27 A 709 ALA ARG VAL TYR SER GLY VAL LEU SER SER GLY ASP SER SEQRES 28 A 709 VAL LEU ASN SER VAL LYS GLY LYS LYS GLU ARG VAL GLY SEQRES 29 A 709 ARG MET VAL GLN MET HIS ALA ASN GLN ARG GLU GLU ILE SEQRES 30 A 709 LYS GLU VAL ARG ALA GLY ASP ILE ALA ALA LEU ILE GLY SEQRES 31 A 709 MET LYS ASP VAL THR THR GLY ASP THR LEU CYS SER ILE SEQRES 32 A 709 GLU LYS PRO ILE ILE LEU GLU ARG MET ASP PHE PRO GLU SEQRES 33 A 709 PRO VAL ILE SER VAL ALA VAL GLU PRO LYS THR LYS ALA SEQRES 34 A 709 ASP GLN GLU LYS MET GLY ILE ALA LEU GLY LYS LEU ALA SEQRES 35 A 709 GLN GLU ASP PRO SER PHE ARG VAL LYS THR ASP GLU GLU SEQRES 36 A 709 SER GLY GLN THR ILE ILE SER GLY MET GLY GLU LEU HIS SEQRES 37 A 709 LEU ASP ILE ILE VAL ASP ARG MET LYS ARG GLU PHE GLY SEQRES 38 A 709 VAL GLU ALA ASN ILE GLY LYS PRO GLN VAL ALA TYR ARG SEQRES 39 A 709 GLU THR ILE THR LYS ASP ASN VAL GLU ILE GLU GLY LYS SEQRES 40 A 709 PHE VAL ARG GLN SER GLY GLY ARG GLY GLN PHE GLY HIS SEQRES 41 A 709 CYS TRP ILE ARG PHE SER ALA ALA ASP VAL ASP GLU LYS SEQRES 42 A 709 GLY ASN ILE THR GLU GLY LEU VAL PHE GLU ASN GLU VAL SEQRES 43 A 709 VAL GLY GLY VAL VAL PRO LYS GLU TYR ILE PRO ALA ILE SEQRES 44 A 709 GLN LYS GLY ILE GLU GLU GLN MET LYS ASN GLY VAL VAL SEQRES 45 A 709 ALA GLY TYR PRO LEU ILE GLY LEU LYS ALA THR VAL PHE SEQRES 46 A 709 ASP GLY SER TYR HIS ASP VAL ASP SER ASN GLU MET ALA SEQRES 47 A 709 PHE LYS ILE ALA ALA SER MET ALA THR LYS GLN LEU ALA SEQRES 48 A 709 GLN LYS GLY GLY GLY LYS VAL LEU GLU PRO ILE MET LYS SEQRES 49 A 709 VAL GLU VAL VAL THR PRO GLU ASP TYR MET GLY ASP VAL SEQRES 50 A 709 MET GLY ASP LEU ASN ARG ARG ARG GLY LEU ILE GLN GLY SEQRES 51 A 709 MET GLU ASP THR VAL SER GLY LYS VAL ILE ARG ALA GLU SEQRES 52 A 709 VAL PRO LEU GLY GLU MET PHE GLY TYR ALA THR ASP VAL SEQRES 53 A 709 ARG SER MET SER GLN GLY ARG ALA SER TYR SER MET GLU SEQRES 54 A 709 PHE SER LYS TYR ALA GLU ALA PRO SER ASN ILE VAL GLU SEQRES 55 A 709 ALA LEU VAL LYS LYS GLN GLY SEQRES 1 B 8 DAL BB9 TRP 0UO GLY DBB DHA SAR MODRES 4FN5 BB9 B 2 CYS MODRES 4FN5 0UO B 4 TRP 4-METHOXY-L-TRYPTOPHAN MODRES 4FN5 DHA B 7 SER 2-AMINO-ACRYLIC ACID MODRES 4FN5 SAR B 8 GLY SARCOSINE HET DAL B 1 4 HET BB9 B 2 6 HET 0UO B 4 16 HET DBB B 6 6 HET DHA B 7 5 HET SAR B 8 5 HETNAM DAL D-ALANINE HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM 0UO 4-METHOXY-L-TRYPTOPHAN HETNAM DBB D-ALPHA-AMINOBUTYRIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM SAR SARCOSINE HETSYN DHA 2,3-DIDEHYDROALANINE FORMUL 2 DAL C3 H7 N O2 FORMUL 2 BB9 C3 H5 N O2 S FORMUL 2 0UO C12 H14 N2 O3 FORMUL 2 DBB C4 H9 N O2 FORMUL 2 DHA C3 H5 N O2 FORMUL 2 SAR C3 H7 N O2 FORMUL 3 HOH *16(H2 O) HELIX 1 1 PRO A 6 ASN A 8 5 3 HELIX 2 2 GLY A 22 LEU A 40 1 19 HELIX 3 3 PHE A 95 LEU A 106 1 12 HELIX 4 4 GLU A 120 GLY A 134 1 15 HELIX 5 5 ASN A 150 GLY A 163 1 14 HELIX 6 6 PRO A 208 GLU A 228 1 21 HELIX 7 7 ASN A 230 GLY A 241 1 12 HELIX 8 8 SER A 244 ALA A 258 1 15 HELIX 9 9 GLY A 274 LEU A 286 1 13 HELIX 10 10 ASP A 427 ASP A 442 1 16 HELIX 11 11 GLY A 462 ARG A 475 1 14 HELIX 12 12 PRO A 549 GLU A 551 5 3 HELIX 13 13 TYR A 552 GLY A 567 1 16 HELIX 14 14 ASN A 592 GLN A 606 1 15 HELIX 15 15 GLN A 606 GLY A 611 1 6 HELIX 16 16 TYR A 630 ASN A 639 1 10 HELIX 17 17 ARG A 640 ARG A 642 5 3 HELIX 18 18 GLY A 664 PHE A 667 5 4 HELIX 19 19 GLY A 668 SER A 677 1 10 HELIX 20 20 PRO A 694 LYS A 704 1 11 SHEET 1 A 7 ALA A 67 TRP A 72 0 SHEET 2 A 7 TYR A 82 ILE A 87 -1 O VAL A 86 N VAL A 68 SHEET 3 A 7 TYR A 10 CYS A 16 1 N ARG A 11 O ARG A 83 SHEET 4 A 7 GLY A 108 CYS A 114 1 O VAL A 112 N CYS A 16 SHEET 5 A 7 ARG A 137 ASN A 142 1 O TYR A 140 N PHE A 113 SHEET 6 A 7 VAL A 262 CYS A 266 1 O PRO A 263 N VAL A 139 SHEET 7 A 7 PRO A 166 PRO A 168 1 N VAL A 167 O VAL A 262 SHEET 1 B 4 GLN A 170 ILE A 173 0 SHEET 2 B 4 GLY A 181 ASP A 184 -1 O GLY A 181 N ILE A 173 SHEET 3 B 4 LYS A 189 ASN A 194 -1 O ILE A 191 N GLN A 182 SHEET 4 B 4 THR A 201 GLU A 204 -1 O THR A 201 N ASN A 194 SHEET 1 C 2 ILE A 295 LYS A 296 0 SHEET 2 C 2 GLU A 308 ARG A 309 -1 O ARG A 309 N ILE A 295 SHEET 1 D 6 GLU A 373 ILE A 374 0 SHEET 2 D 6 MET A 363 VAL A 364 -1 N MET A 363 O ILE A 374 SHEET 3 D 6 ILE A 382 LEU A 385 -1 O ALA A 384 N VAL A 364 SHEET 4 D 6 PHE A 335 SER A 340 -1 N ALA A 336 O ALA A 383 SHEET 5 D 6 SER A 318 LYS A 323 -1 N LYS A 323 O PHE A 335 SHEET 6 D 6 THR A 396 CYS A 398 -1 O LEU A 397 N SER A 319 SHEET 1 E 2 LEU A 343 SER A 344 0 SHEET 2 E 2 GLU A 376 VAL A 377 -1 O VAL A 377 N LEU A 343 SHEET 1 F 3 ILE A 416 VAL A 420 0 SHEET 2 F 3 GLN A 455 GLY A 460 -1 O ILE A 458 N VAL A 418 SHEET 3 F 3 ARG A 446 ASP A 450 -1 N LYS A 448 O ILE A 457 SHEET 1 G 3 ARG A 491 THR A 493 0 SHEET 2 G 3 LYS A 614 PRO A 627 -1 O LEU A 616 N ARG A 491 SHEET 3 G 3 SER A 682 SER A 684 -1 O SER A 682 N VAL A 625 SHEET 1 H 4 LEU A 644 ASP A 650 0 SHEET 2 H 4 GLY A 654 PRO A 662 -1 O GLU A 660 N LEU A 644 SHEET 3 H 4 LYS A 614 PRO A 627 -1 N VAL A 624 O ILE A 657 SHEET 4 H 4 PHE A 687 GLU A 692 -1 O SER A 688 N ILE A 619 SHEET 1 I 4 VAL A 499 SER A 509 0 SHEET 2 I 4 ARG A 512 SER A 523 -1 O CYS A 518 N GLY A 503 SHEET 3 I 4 GLY A 576 ASP A 583 -1 O PHE A 582 N TRP A 519 SHEET 4 I 4 GLY A 536 ASN A 541 1 N VAL A 538 O LEU A 577 LINK C DAL B 1 N BB9 B 2 1555 1555 1.33 LINK C BB9 B 2 N TRP B 3 1555 1555 1.34 LINK C TRP B 3 N 0UO B 4 1555 1555 1.36 LINK C 0UO B 4 N GLY B 5 1555 1555 1.34 LINK C DBB B 6 N DHA B 7 1555 1555 1.34 LINK C DHA B 7 N SAR B 8 1555 1555 1.37 LINK N DAL B 1 C SAR B 8 1555 1555 1.35 LINK C DAL B 1 SG BB9 B 2 1555 1555 1.78 SITE 1 AC1 17 GLU A 413 PRO A 414 SER A 417 ARG A 446 SITE 2 AC1 17 LYS A 448 ASP A 450 ILE A 457 SER A 459 SITE 3 AC1 17 PRO A 486 GLN A 487 VAL A 488 ALA A 489 SITE 4 AC1 17 PRO A 618 MET A 620 LEU A 663 MET A 685 SITE 5 AC1 17 PHE A 687 CRYST1 125.780 88.100 74.320 90.00 107.91 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007950 0.000000 0.002569 0.00000 SCALE2 0.000000 0.011351 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014141 0.00000